Notificações de reações adversas associadas a ciprofloxacino, amoxicilina, ceftriaxona e sulfametoxazol + trimetoprima em idosos no Brasil, 2021-2025

Igor José Dias e Silva, Mariana Rosa de Souza, Vitoria Vicentina Lima Ferreira, Letícia Silva Oliveira, Luciana Vieira Queiroz Labre · 2026

Read Notificações de reações adversas associadas a ciprofloxacino, amoxicilina, ceftriaxona e sulfametoxazol + trimetoprima em idosos no Brasil, 2021-2025 by Igor José Dias e Silva, Mariana Rosa de Souza, Vitoria Vicentina Lima Ferreira, Letícia Silva Oliveira, Luciana Vieira Queiroz Labre (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7213766514.txt.

Description

Igor José Dias e Silva and co-workers analyse adverse reaction reports for four antibiotics in older Brazilians. Their 2026 study covers notifications from 2021 to 2025. Ageing, multiple medicines, and other illnesses can raise the risk of drug reactions in this group.

Over twenty-seven hundred drug-linked notifications were identified. Ceftriaxone accounted for more than half, used by ciprofloxacin, a combined sulfa drug, and amoxicillin. The Southeast region gathered over half of all reports. The team examined severity, outcomes, age group, and the body system affected, counting unique reports carefully to avoid duplication. Such monitoring, they imply, is essential for safer antibiotic use in older patients.

Catalog record

CREATORIgor José Dias e Silva, Mariana Rosa de Souza, Vitoria Vicentina Lima Ferreira, Letícia Silva Oliveira, Luciana Vieira Queiroz Labre
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE68 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEOpenAlex / Research Society and Development

Source: https://doi.org/10.33448/rsd-v15i9.51717

Browse the full library · About the Tower of Babel